SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-005571
Filing Date
2023-04-06
Accepted
2023-04-06 16:30:37
Documents
12
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K pasg-20230331x8k.htm   iXBRL 8-K 41820
  Complete submission text file 0001558370-23-005571.txt   165982

Data Files

Seq Description Document Type Size
2 EX-101.SCH pasg-20230331.xsd EX-101.SCH 3047
3 EX-101.LAB pasg-20230331_lab.xml EX-101.LAB 16577
4 EX-101.PRE pasg-20230331_pre.xml EX-101.PRE 10457
6 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20230331x8k_htm.xml XML 5058
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 23806560
SIC: 2836 Biological Products, (No Diagnostic Substances)